Syra Health Corp. Class A Common Stock
SYRA
SYRA was delisted on the 17th of April, 2025.
9 hedge funds and large institutions have $94.8K invested in Syra Health Corp. Class A Common Stock in 2024 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 3 closing their positions.
0% more funds holding
Funds holding: 9 → 9 (0)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
24% less capital invested
Capital invested by funds: $125K → $94.8K (-$30.5K)
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$18.1K |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$165 |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$22 |
| 4 |
JP Morgan Chase
New York
|
+$8 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
-$17.2K |
| 2 |
TSS
Two Sigma Securities
New York
|
-$14.6K |
| 3 |
DLCIG
D.L. Carlson Investment Group
Concord,
New Hampshire
|
-$13.8K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$2.45K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$131 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Vanguard Group
Malvern,
Pennsylvania
| $46.9K | – | – | – |
|
|
XT
2
XTX Topco
George Town,
Cayman Islands
| $18.2K | +$18.1K | +13,274 | New |
|
|
3
Geode Capital Management
Boston,
Massachusetts
| $17.8K | -$17.2K | -12,590 | -49% |
|
|
TRCT
4
Tower Research Capital (TRC)
New York
| $8.1K | -$131 | -96 | -2% |
|
|
5
UBS Group
Zurich,
Switzerland
| $2.28K | -$2.45K | -1,791 | -52% |
|
|
NA
6
NewEdge Advisors
New Orleans,
Louisiana
| $1.37K | – | – | – |
|
|
7
Fidelity Investments
Boston,
Massachusetts
| $166 | +$165 | +121 | New |
|
|
8
Bank of America
Charlotte,
North Carolina
| $22 | +$22 | +16 | New |
|
|
9
JP Morgan Chase
New York
| $14 | +$8 | +6 | +150% |
|
|
TSS
10
Two Sigma Securities
New York
| – | -$14.6K | -10,545 | Closed |
|
|
DLCIG
11
D.L. Carlson Investment Group
Concord,
New Hampshire
| – | -$13.8K | -10,000 | Closed |
|
12
Wells Fargo
San Francisco,
California
| – | -$22 | -16 | Closed |
|
SYRA Hedge Fund Activity: Q2 2024 in Review
9 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Syra Health Corp. Class A Common Stock (SYRA) for Q2 2024, worth a combined $94.8K — down 24% from $125K a quarter earlier.
Fund positioning in SYRA was balanced in Q2 2024: 3 funds opened new positions, 3 closed out, 1 added to existing stakes and 3 trimmed.
The largest buyer was XTX Topco, opening a new position worth an estimated $18.1K. The largest seller was Geode Capital Management, cutting an estimated $17.2K.
- 9 institutional investors held Syra Health Corp. Class A Common Stock (SYRA) as of Q2 2024, unchanged from Q1 2024.
- Funds reported $94.8K of Syra Health Corp. Class A Common Stock stock for Q2 2024, down 24% quarter-over-quarter.
- 3 funds opened new Syra Health Corp. Class A Common Stock positions in Q2 2024 and 3 closed out, a net change of 0 holders.
- The largest Syra Health Corp. Class A Common Stock buyer in Q2 2024 was XTX Topco, an estimated $18.1K added.
- The largest Syra Health Corp. Class A Common Stock seller in Q2 2024 was Geode Capital Management, an estimated $17.2K sold.
Based on aggregated 13F filings for Q2 2024.